NONACUS LIMITED

Active United Kingdom

Research and experimental development on biotechnology

56 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
N

NONACUS LIMITED

Research and experimental development on biotechnology

Founded 14 May 2015 Active United Kingdom 56 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 14 Oct 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 9 Jul 2025 Next due 23 Jul 2026 2 months remaining
Net assets £13M £7M 2024 year on year
Total assets £14M £7M 2024 year on year
Total Liabilities £856K £88K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for NONACUS LIMITED (09590278), an active life sciences and medical technology company based in United Kingdom. Incorporated 14 May 2015. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2016–2024)

Cash in Bank

£5.29M

Decreased by £5.33M (-50%)

Net Assets

£13.12M

Decreased by £6.73M (-34%)

Total Liabilities

£855.99k

Increased by £88.10k (+11%)

Turnover

£2.53M

Increased by £410.66k (+19%)

Employees

56

Decreased by 2 (-3%)

Debt Ratio

6%

Increased by 2 (+50%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Officers

Officers

2 active 1 resigned
Status
Christopher David SaleDirectorBritishEngland4914 May 2015Active
Graham Robert SnuddenDirectorBritishEngland6224 Mar 2016Active

Shareholders

Shareholders (1)

Advanced Genomics Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 3 Ceased
Active
Notified 27 Jun 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Graham Robert Snudden

Ceased 27 Jun 2023

Ceased

Lee Daniel Silcock

Ceased 27 Jun 2023

Ceased

Christopher David Sale

Ceased 27 Jun 2023

Ceased

Group Structure

Group Structure

NONACUS LIMITED Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Mar 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
14 Oct 2025AccountsAnnual accounts filed
14 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
2 Oct 2025OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
2 Oct 2025OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
30 Mar 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

14 Oct 2025 Accounts

Annual accounts filed

14 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

2 Oct 2025 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

2 Oct 2025 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

Recent Activity

Latest Activity

Mortgage Create With Deed With Charge Number Charge Creation Date

1 months ago on 30 Mar 2026

Annual accounts filed

6 months ago on 14 Oct 2025

Annual accounts made up to 31 Dec 2024

6 months ago on 14 Oct 2025

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

7 months ago on 2 Oct 2025

Audit exemption statement of guarantee by parent company for period ending 31/12/24

7 months ago on 2 Oct 2025